Brookstone Capital Management Invests $634,000 in Option Care Health, Inc. $OPCH

Brookstone Capital Management purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the first quarter, Holdings Channel reports. The institutional investor purchased 23,558 shares of the company’s stock, valued at approximately $634,000.

Several other hedge funds also recently made changes to their positions in the stock. Sheets Smith Wealth Management boosted its stake in Option Care Health by 18.6% in the 1st quarter. Sheets Smith Wealth Management now owns 31,030 shares of the company’s stock worth $835,000 after purchasing an additional 4,863 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Option Care Health by 97.1% in the fourth quarter. Pacer Advisors Inc. now owns 42,121 shares of the company’s stock worth $1,342,000 after purchasing an additional 20,751 shares during the period. Invesco Ltd. increased its holdings in shares of Option Care Health by 19.6% in the fourth quarter. Invesco Ltd. now owns 534,551 shares of the company’s stock worth $17,031,000 after purchasing an additional 87,721 shares during the period. EP Wealth Advisors LLC purchased a new stake in shares of Option Care Health in the fourth quarter worth $225,000. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock valued at $221,707,000 after buying an additional 752,058 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Option Care Health news, CEO John Charles Rademacher purchased 12,500 shares of Option Care Health stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the transaction, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the purchase, the director directly owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. This represents a 8.86% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 73,264 shares of company stock valued at $1,548,316 over the last quarter. 1.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

OPCH has been the subject of several recent analyst reports. Zacks Research cut Option Care Health from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. Morgan Stanley set a $28.00 price target on Option Care Health in a research report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a report on Friday, May 1st. The Goldman Sachs Group started coverage on shares of Option Care Health in a research report on Monday, June 8th. They issued a “neutral” rating and a $22.00 price objective on the stock. Finally, UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Trading Up 1.6%

NASDAQ OPCH opened at $21.82 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The stock’s 50-day simple moving average is $22.38 and its two-hundred day simple moving average is $28.65. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a market capitalization of $3.43 billion, a price-to-earnings ratio of 16.91, a PEG ratio of 1.21 and a beta of 0.67.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company’s revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts forecast that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.